Warfarin is significantly underutilized for stroke prevention in older patients with chronic nonvalvular atrial fibrillation who are at high risk for thromboembolic events.
Warfarin underuse in high-risk older AF patients warrants attention; leaves open barriers and strategies to improve uptake.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mendelson et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: